Facts

• PCT patent publication
  WO 2021/219255 dated 04.11.2021
• dosing and adhesive layer certified
  according to EN ISO 10993-5 and 10993-10,
  suitable for direct adhesion to human skin
• production according to GMP guidelines in
  accordance with EN ISO 22716
• EN ISO 13485:2016 (medical product)
  EN ISO 9001:2015
  EN ISO 14001:2015
• dermatologically safe
• latex-free
• water vapour permeable

ADHESION POWER

up to 20 N per 25 mm at contact time 24 hours
(following AFERA 5001)

PERMEABLE TRANSITION AREA

5–100%

PAD SIZE

1 cm² up to 200 cm² 

TOTAL PRODUCT THICKNESS

0.4–2.0 mm

SOURCE MATERIAL

jumbo coil 125 cm width x 200 running metres
on 3“ or 6“ core

FORMATION

• lifting and rotary die-cutting
• kiss-cutting
• island dressing
• laser-cutting

USUAL MATERIAL WEIGHT UNLOADED

50–1000 g/m 

LOADING CAPACITY

up to 1000 % of the product weight

TENSILE STRENGTH

60 N/5 cm

ELONGATION

up to approx. 45 %

SUBMISSION CAPACITY TO THE SKIN

• can be controlled via the dosing and adhesive layer
• depending on the active substance, 65–85 % of the loading capacity within 6 hours until body saturation is reached.

DURATION OF EFFECT

• doseable from 15 min. to 7 days

STORAGE

• steam-tight packed: 12 months
  store protected from light and dry
  between 0 °C and +25 °C
• unpacked ready for use: approx. 1 % charge loss
  per 10 days over edge, liner and top layer
  (tested in ventilated climate chamber at +25 °C)

VEGAN

CLIMATE-NEUTRAL PRODUCTION IN AUSTRIA